Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

Date: February 22, 2017
Pages: 57
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EA84063DD6AEN
Leaflet:

Download PDF Leaflet

Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review
Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Eisai Co Ltd (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides chemicals, food ingredients and additives, dietary supplements and cosmetics. The company’s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases. Eisai’s major products include proton pump inhibitor; Aricept, an anti-Alzheimer's agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others. Eisai has ten major subsidiaries, two production plants, a research lab and an industrial complex. Outside Japan, the company operates in North America, Europe and Asia. Eisai is headquartered in Tokyo, Japan.

Eisai Co Ltd Key Recent Developments

Jan 18, 2017: Eisai To Participate In Access Accelerated, Global Partnership To Address Rise Of Non-Communicable Diseases
Jan 12, 2017: Eisai To Launch Medication Administration Support Device e-OKUSURI-SAN
Sep 14, 2016: Eisai Selected For Fourth Consecutive Year Of Membership In Dow Jones Sustainability Asia Pacific Index 2016
Aug 23, 2016: EISAI To Launch Chocola BB Mouth Ulcer Repair Shot
Jul 11, 2016: NTT IT, NTT East and Eisai Rollout Interprofessional Collaboration Business for Medical Treatment and Care

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Eisai Co Ltd - Key Facts
    Eisai Co Ltd - Key Employees
    Eisai Co Ltd - Key Employee Biographies
    Eisai Co Ltd - Key Operational Employees
    Eisai Co Ltd - Major Products and Services
    Eisai Co Ltd - Pharmaceutical Pipeline Products Data
    Eisai Co Ltd, Pipeline Products by Therapy Area
    Eisai Co Ltd, Pipeline Products by Development Phase
    Eisai Co Ltd - History
    Eisai Co Ltd - Company Statement
    Eisai Co Ltd - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Eisai Co Ltd - Business Description
    Eisai Co Ltd - Corporate Strategy
    Eisai Co Ltd - SWOT Analysis
    SWOT Analysis - Overview
    Eisai Co Ltd - Strengths
    Eisai Co Ltd - Weaknesses
    Eisai Co Ltd - Opportunities
    Eisai Co Ltd - Threats
    Eisai Co Ltd - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    Eisai Co Ltd, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jan 18, 2017: Eisai To Participate In Access Accelerated, Global Partnership To Address Rise Of Non-Communicable Diseases
    Jan 12, 2017: Eisai To Launch Medication Administration Support Device e-OKUSURI-SAN
    Aug 23, 2016: EISAI To Launch Chocola BB Mouth Ulcer Repair Shot
    Jul 11, 2016: NTT IT, NTT East and Eisai Rollout Interprofessional Collaboration Business for Medical Treatment and Care
    Jun 30, 2016: Eisai Listed For 15th Consecutive Year In FTSE4Good Index Series, An Index For Socially Responsible Investment
    Apr 06, 2016: Eisai and PharmStandard Sign Cooperation Agreements in Russia
    Feb 15, 2016: Eisai and Charles River Laboratories Announce Collaboration for New Drug Discovery

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Eisai Co Ltd, Key Facts
    Eisai Co Ltd, Key Employees
    Eisai Co Ltd, Key Employee Biographies
    Eisai Co Ltd, Key Operational Employees
    Eisai Co Ltd, Major Products and Services
    Eisai Co Ltd, Number of Pipeline Products by Therapy Area
    Eisai Co Ltd, Number of Pipeline Products by Development Stage
    Eisai Co Ltd, History
    Eisai Co Ltd, Subsidiaries
    Eisai Co Ltd, Joint Venture
    Eisai Co Ltd, Key Competitors
    Eisai Co Ltd, Ratios based on current share price
    Eisai Co Ltd, Annual Ratios
    Eisai Co Ltd (Cont...1), Annual Ratios
    Eisai Co Ltd, Interim Ratios
    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    Eisai Co Ltd, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Eisai Co Ltd, Pipeline Products by Therapy Area
    Eisai Co Ltd, Pipeline Products by Development Phase
    Eisai Co Ltd, Performance Chart (2012 - 2016)
    Eisai Co Ltd, Ratio Charts
    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
    Skip to top


    Ask Your Question

    Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: